Wharton’s Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy: A Pilot Study

Wharton’s jelly-derived mesenchymal stem cells (WJ-MSCs) have been introduced as a possible therapy in hypoxic-ischemic encephalopathy (HIE). We report a 16-year-old boy who was treated with WJ-MSCs in the course of HIE due to post-cardiopulmonary resuscitation. He received a long period of mechanic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kabataş, Serdar, Civelek, Erdinç, İnci, Çiğdem, Yalçınkaya, Ebru Yılmaz, Günel, Gülşen, Kır, Gülay, Albayrak, Esra, Öztürk, Erek, Adaş, Gökhan, Karaöz, Erdal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180731/
https://www.ncbi.nlm.nih.gov/pubmed/30203688
http://dx.doi.org/10.1177/0963689718786692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180731/
https://www.ncbi.nlm.nih.gov/pubmed/30203688
http://dx.doi.org/10.1177/0963689718786692

Ejemplares similares